These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1515999)

  • 21. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis.
    Bauer LA; O'Sullivan T; Reiss WG; Horn JR; Opheim K; Strandness DE; Carithers RL
    Br J Clin Pharmacol; 1994 Apr; 37(4):375-81. PubMed ID: 8018459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of functional liver reserve in patients before cardiac surgery using antipyrine plasma clearance test.
    Takeda M; Furuse A; Kawauchi M; Kotsuka Y; Takamoto S
    J Cardiovasc Surg (Torino); 1999 Dec; 40(6):817-23. PubMed ID: 10776711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipyrine Metabolism during Chemotherapy with 5-Fluorouracil Plus Folinic Acid in Patients with Liver Metastases from Primary Colorectal Cancer.
    Grieco A; Castellano R; Matera A; Ragazzoni E; Fontana T; Barone C
    Am J Ther; 1994 Dec; 1(4):255-259. PubMed ID: 11835096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antipyrine clearance as a measure of drug metabolism in patients with diabetes mellitus].
    Oltmanns D; Dennin DE; Pentz R; Siegers CP
    Z Gastroenterol; 1984 Oct; 22(10):598-601. PubMed ID: 6506825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of effect of zinc supplementation on antipyrine clearance in alcoholic liver disease.
    Grønbaek K; Friis H; Feldman M; Sonne J; Andreasen PB
    Eur J Clin Pharmacol; 1996; 49(5):397-9. PubMed ID: 8866636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Beppu T; Sugiura M; Sanjo K; Idezuki Y
    Clin Pharmacol Ther; 1988 Aug; 44(2):217-24. PubMed ID: 3396264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of quantitative methods to assess hepatic function: Pugh's classification, indocyanine green, antipyrine, and dextromethorphan.
    Figg WD; Dukes GE; Lesesne HR; Carson SW; Songer SS; Pritchard JF; Hermann DJ; Powell JR; Hak LJ
    Pharmacotherapy; 1995; 15(6):693-700. PubMed ID: 8602375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antipyrine clearance in liver resections].
    Fiorentini MT; Fracchia M; Biondi AM; Capussotti L; De La Pierre M; Molino G
    Minerva Dietol Gastroenterol; 1990; 36(4):209-13. PubMed ID: 2089284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease.
    Homeida M; Roberts CJ; Halliwell M; Read AE; Branch RA
    Gut; 1979 Jul; 20(7):596-601. PubMed ID: 488757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in salivary antipyrine pharmacokinetics during adolescence, correlated with age, hormonal levels and Tanner stage.
    Linday LA; Greenblatt DJ; Warren MP; Harmatz JS; DeCresce R; Cicalese C; LeDuc BW
    Dev Pharmacol Ther; 1991; 16(4):194-202. PubMed ID: 1782837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diurnal variability of hepatic clearance of antipyrine and Tc-99m-HIDA in healthy persons and in those with liver diseases. I].
    Hartleb M; Markiewicz A; Rudzki K; Nowak S; Bołdys H; Kacperek T
    Pol Arch Med Wewn; 1987 Jun; 77(6):264-9. PubMed ID: 3271278
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacokinetics of antipyrine in viral and alcoholic lesions of the liver].
    Tsyrkunov VM; Bushma MI; Garelik PV; Novitskiĭ GK; Zavodnik LB
    Klin Med (Mosk); 1989 Feb; 67(2):87-9. PubMed ID: 2724896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of antineoplastic chemotherapy on antipyrine metabolism in man.
    Wissel PS; Sordillo P; Magill GB
    J Clin Pharmacol; 1989 Mar; 29(3):267-9. PubMed ID: 2498398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ciprofloxacin on the pharmacokinetics of antipyrine in healthy volunteers.
    Tan KK; Allwood MC; Shawket S
    J Clin Pharm Ther; 1990 Apr; 15(2):151-4. PubMed ID: 2341493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of prednisolone on antipyrine elimination in patients with obstructive lung disease.
    Loft S; Simonsen K; Evald T; Christensen HR; Sonne J; Døssing M
    Eur J Clin Pharmacol; 1987; 33(1):89-91. PubMed ID: 3691602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrine.
    Crom WR; Relling MV; Christensen ML; Rivera GK; Evans WE
    Clin Pharmacol Ther; 1991 Aug; 50(2):132-40. PubMed ID: 1868674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of physical exercise on one-sample antipyrine clearance.
    Fabbri A; Bianchi G; Zoli M; Marchi E; Marchesini G
    Ital J Gastroenterol; 1991 Feb; 23(2):74-6. PubMed ID: 1747507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.